Search results for: 'complex therapies'

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

Wounds, especially chronic wounds, are associated with clinical, social, and economic challenges. Wounds resulting from diabetes, injuries, and surgeries affect a significant population globally. According to an economic evaluation study on Medicare beneficiaries, 8.2 million people in the United States have at least one type of chronic wound. Amon...

This research identifies some the key developments across CAR-T cell therapies and provides insights across technological, IP, and investment landscapes. The study also provides an analysis of the competitive landscape while highlighting the key growth opportunities within the CAR-T cell therapy platform.

23 Oct 2020  |  North America  |  Market Research

Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026

Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities

Infographics

×

Key Issues Addressed

In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...

Currently there is a huge demand for healthcare services outside the hospitals and clinics, into the home environment, with healthwear meeting the needs of this growing trend and demand. The wearable medical devices integrated with vital signs or motion sensors can be used for continuous remote monitoring of patients, especially vulnerable chronic ...

The mobile and wireless technologies have revolutionized the healthcare service delivery across the globe. Mobile and Internet based healthcare therapies and services in form of patient monitoring devices or personal digital assistants provide great connectivity and convenience. This research service (RS) showcases the innovations in digital and mo...

The research provides technological advances and insights across non-opioid pharmaceuticals for the management of pain. Key application areas explored in the research include neuropathic pain, migrane, post-surgical pain, cancer pain, chronic pain and migraine. The research encompasses technological advances across Nav1.7 inhibitors, Calcitonin Gen...

This research service provides an understanding of the significance and impact of digital therapeutics on the emerging applications. Digital therapeutics is evidence-based therapeutic intervention for prevention, management, and treatment of a specific disease condition; it has the potential to address needs that traditional treatments and therapie...

As part of Frost & Sullivan’s ongoing research on Cybersecurity, we conducted a deep-dive into the Global DDoS Mitigation market. Distributed Denial of Service (DDoS), among the most common hacker attacks, overwhelms network hosts with invalid requests from 'distributed’ sources, leading to legitimate requests being lost or ignored in the ensuing m...